Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study

The metabolic effect of intratumor cholesteryl ester (CE) in breast cancer remains poorly understood. The objective was to analyze the relationship between intratumor CE content and clinicopathological variables in human breast carcinomas. We classified 30 breast carcinoma samples into three subgroups: 10 luminal-A tumors (ER+/PR+/Her2-), 10 Her-2 tumors (ER-/PR-/Her2+), and 10 triple negative (TN) tumors (ER-/PR-/Her2-). We analyzed intratumor neutral CE, free cholesterol (FC) and triglyceride (TG) content by thin layer chromatography after lipid extraction. RNA and protein levels of lipid metabolism and invasion mediators were analyzed by real time PCR and Western blot analysis. Group-wise comparisons, linear regression and logistic regression models showed a close association between CE-rich tumors and higher histologic grade, Ki-67 and tumor necrosis. CE-rich tumors displayed higher mRNA and protein levels of low-density lipoprotein receptor (LDLR) and scavenger receptor class B member 1 (SCARB1). An increased expression of acetyl-Coenzyme A acetyltransferase 1 (ACAT1) in CE-rich tumors was also reported. Intratumor CE accumulation is intimately linked to proliferation and aggressive potential of breast cancer tumors. Our data support the link between intratumor CE content and poor clinical outcome and open the door to new antitumor interventions.

• Publication year

  2015

• Venue

  BMC Cancer

• Publication date

  2015-06-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/s12885-015-1469-5PMID 26055977PMCID 4460760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PloS One 2012

  2015cited by this paper
• LDL-cholesterol signaling induces breast cancer proliferation and invasion

  2014cited by this paper
• Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.

  2014cited by this paper
• Hypoxia Induces Metalloproteinase-9 Activation and Human Vascular Smooth Muscle Cell Migration Through Low-Density Lipoprotein Receptor–Related Protein 1–Mediated Pyk2 Phosphorylation

  2013cited by this paper
• Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model

  2013cited by this paper
• Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer

  2013cited by this paper
• 27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology

  2013cited by this paper
• Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development

  2013cited by this paper
• Hypoxia Induces Metalloproteinase-9 Activation and Human Vascular Smooth Muscle Cell Migration Through Low-Density Lipoprotein Receptor–Related Protein 1–Mediated Pyk2 Phosphorylation

  2013cited by this paper
• 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.

  2013cited by this paper
• Lipid metabolism in cancer.

  2013cited by this paper
• Cancer: Destiny from density

  2012cited by this paper
• CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues.

  2012cited by this paper
• HDL of Patients with Type 2 Diabetes Mellitus Elevates the Capability of Promoting Breast Cancer Metastasis

  2012cited by this paper
• The Lipid Phenotype of Breast Cancer Cells Characterized by Raman Microspectroscopy: Towards a Stratification of Malignancy

  2012cited by this paper
• High‐density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells

  2012cited by this paper
• Cholesterol and breast cancer development.

  2012cited by this paper
• Lipid metabolism in cancer

  2012cited by this paper
• Gene signatures of breast cancer progression and metastasis

  2011cited by this paper
• A refined molecular taxonomy of breast cancer

  2011cited by this paper
• Low-density lipoprotein receptor-related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas.

  2011cited by this paper
• Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression.

  2011cited by this paper
• Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification

  2011influential reference
• Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors

  2010cited by this paper
• Tumorigenesis and Neoplastic Progression Role of Cholesterol in the Development and Progression of Breast Cancer

  2010cited by this paper
• Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?

  2010cited by this paper
• Tumor necrosis is a new promising prognostic factor in colorectal cancer.

  2010cited by this paper
• Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells

  2010cited by this paper
• High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation

  2010cited by this paper
• CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior

  2009cited by this paper
• Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion

  2009cited by this paper
• Predicting protein-protein interactions in Arabidopsis thaliana through integration of orthology, gene ontology and co-expression

  2009cited by this paper
• Inflammation and mitochondrial fatty acid β-oxidation link obesity to early tumor promotion

  2009cited by this paper
• Significance of Alterations in Plasma Lipid Profile Levels in Breast Cancer

  2008cited by this paper
• Aggregated low density lipoproteins decrease metalloproteinase-9 expression and activity in human coronary smooth muscle cells.

  2007cited by this paper
• Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

  2007cited by this paper
• Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

  2006cited by this paper
• Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer

  2006cited by this paper
• The Prototypical Inhibitor of Cholesterol Esterification, Sah 58-035 [3-[Decyldimethylsilyl]-N-[2-(4-methylphenyl)-1-phenylethyl]propanamide], Is an Agonist of Estrogen Receptors

  2006cited by this paper
• Cholesteryl esters in malignancy.

  2005cited by this paper
• A Mutant High-Density Lipoprotein Receptor Inhibits Proliferation of Human Breast Cancer Cells

  2004cited by this paper
• Pathology and Genetics of Tumours of the Breast and Female Genital Organs

  2003cited by this paper
• Overweight, obesity, and cancer risk.

  2002cited by this paper
• Role of lipids, lipoproteins and vitamins in women with breast cancer.

  2001cited by this paper
• LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells.

  2000cited by this paper
• The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptake.

  2000cited by this paper
• Scavenger Receptor Class B, Type I, Mediates Selective Uptake of Low Density Lipoprotein Cholesteryl Ester*

  1999cited by this paper
• Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors.

  1998cited by this paper
• Effects of low‐ and high‐density lipoproteins on the proliferation of human breast cancer cells In vitro: Differences between hormone‐dependent and hormone‐independent cell lines

  1989cited by this paper
• Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease.

  1984cited by this paper

• Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria

  2025cites this paper
• Scavenger receptor class B member 1 promotes lung cancer growth and metastasis through enhanced twist family BHLH transcription factor 1 signaling in vitro and in vivo: Exploration of RPPNs as a therapeutic Strategy

  2025cites this paper
• The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy

  2025cites this paper
• Employing low-density lipoprotein-based delivery systems for the treatment of hepatocellular carcinoma.

  2025cites this paper
• Loss of CDS1 impairs the tumorigenic characteristics of nasopharyngeal carcinoma by modulating lipid metabolism

  2025cites this paper
• HSP90 deficiency promotes cholesteryl ester accumulation in lipid droplets via endocytosis of low-density lipoprotein

  2025cites this paper
• Engineering a Viscosity-Gated Dual-Rotor Probe for Comprehensive Mapping of Lipid Droplet Heterogeneity.

  2025cites this paper
• Metabolic Signature in Combination with Fecal Immunochemical Test as a Non-Invasive Tool for Advanced Colorectal Neoplasia Diagnosis

  2025cites this paper
• Fibroblast growth factor receptor signaling modulates cholesterol storage in a SOAT1-dependent manner to promote mammary tumor cell invasion

  2025cites this paper
• Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma

  2025cites this paper
• Lipids: Driving Forces in the Underlying Biology of Carcinogenesis.

  2025cites this paper
• Cholesterol acyltransferase-1: a novel diagnostic biomarker and potential therapeutic target for cancer.

  2025cites this paper
• Nomogram for reducing unnecessary biopsies of breast lesions based on MRI and clinical features: a multi-center retrospective cohort study

  2025cites this paper
• Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment

  2025cites this paper
• Distinct lipidomic profiles in breast cancer cell lines relate to proliferation and EMT phenotypes.

  2025cites this paper
• Bioinformatics Analysis Identifies Lipid Droplet‐Associated Gene Signatures as Promising Prognostic and Diagnostic Models for Endometrial Cancer

  2025cites this paper
• Hypoxanthine activates PI3K/AKT pathway and lipid metabolism, hallmarks in breast cancer metastasis

  2025cites this paper
• The Converging Roles of microRNAs and Lipid Metabolism in Atherosclerotic Cardiovascular Disease and Cancer.

  2025cites this paper
• Dual Receptor Targeting Ensures Uptake and Anticancer Efficacy of Low-Density Lipoprotein-Docosahexaenoic Acid Nanoparticles Across Breast Cancer Cell Subtypes

  2025cites this paper
• The Expression of the LDLR, LDLRAP1, and PCSK9 Genes has Prognostic Significance in Triple-negative Breast Cancer.

  2025cites this paper
• ACAT2 may be a novel predictive biomarker and therapeutic target in lung adenocarcinoma

  2024cites this paper
• Roles of posttranslational modifications in lipid metabolism and cancer progression

  2024cites this paper
• An analysis of the association between breast density and body mass index with breast cancer molecular subtypes in early breast cancer: data from a Spanish population

  2024cites this paper
• Different Roles of Tocopherols and Tocotrienols in Chemoprevention and Treatment of Prostate Cancer

  2024cites this paper
• Assessing the causal relationships between circulating metabolic biomarkers and breast cancer by using mendelian randomization

  2024cites this paper
• Prediction model for ocular metastasis of breast cancer: machine learning model development and interpretation study

  2024cites this paper
• Adaptations of membrane trafficking in cancer and tumorigenesis

  2024cites this paper
• From mitochondria to tumor suppression: ACAT1's crucial role in gastric cancer

  2024cites this paper
• Clinically relevant body composition phenotypes are associated with distinct circulating cytokine and metabolomic milieus in epithelial ovarian cancer patients

  2024cites this paper
• Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer

  2024cites this paper
• Targeting cholesterol impairs cell invasion of all breast cancer types

  2024cites this paper
• Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment

  2024cites this paper
• 1H-NMR metabolomics analysis identifies hypoxanthine as a novel metastasis-associated metabolite in breast cancer

  2024cites this paper
• Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers

  2024cites this paper
• Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer

  2024cites this paper
• LncRNA-encoded Micropeptide ACLY‍-‍BP drives lipid deposition and cell proliferation in Clear Cell Renal Cell Carcinoma via maintenance of ACLY acetylation.

  2023cites this paper
• A sterol‐PI(4)P exchanger modulates the Tel1/ATM axis of the DNA damage response

  2023cites this paper
• Is cholesterol a risk factor for breast cancer incidence and outcome?

  2023cites this paper
• The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape

  2023cites this paper
• Evaluation of sterol‑o‑acyl transferase 1 and cholesterol ester levels in plasma, peritoneal fluid and tumor tissue of patients with endometrial cancer: A pilot study

  2023cites this paper
• Hsa_circ_0003098 promotes bladder cancer progression via miR-377-5p/ACAT2 axis.

  2023cites this paper
• The role of lipid metabolism in cancer radioresistance

  2023cites this paper
• Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors

  2023cites this paper
• The evolving landscape of PCSK9 inhibition in cancer.

  2023cites this paper
• Lipogenesis promotes mitochondrial fusion and maintains cancer stemness in human NSCLC

  2023cites this paper
• The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer

  2023cites this paper
• Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification

  2023cites this paper
• The utility of 3D models to study cholesterol in cancer: Insights and future perspectives

  2023cites this paper
• Lipid remodeling by hypoxia aggravates migratory potential in pancreatic cancer while maintaining membrane homeostasis

  2023cites this paper
• Global lipid remodelling by hypoxia aggravates migratory potential in pancreatic cancer while maintaining plasma membrane homeostasis.

  2023cites this paper
• Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study

  2023cites this paper
• Lysosomal acid lipase-activity as a novel target to efficiently address triple-negative breast cancer high malignancy

  2023cites this paper
• Lipid metabolism reprogramming in head and neck cancer

  2023cites this paper
• miRNA‐128 and miRNA‐223 regulate cholesterol‐mediated drug resistance in breast cancer

  2023cites this paper
• SCARB1 in extracellular vesicles promotes NPC metastasis by co-regulating M1 and M2 macrophage function

  2023cites this paper
• Photodynamic therapy with verteporfin accelerates apoptotic bleb formation in human ameloblastoma.

  2023cites this paper
• The role of cholesterol metabolism in tumor therapy, from bench to bed

  2023cites this paper
• The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling

  2023cites this paper
• Identification of molecular subtypes and a six-gene risk model related to cuproptosis for triple negative breast cancer

  2022cites this paper
• Diet, lipids, and antitumor immunity

  2022cites this paper
• In Vivo Assessments of Mesoblastic Nephroma (Ne/De) and Myelomonoblastic Leukaemia (My1/De) Tumour Development in Hypercholesterolemia Rat Models

  2022cites this paper
• Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions

  2022cites this paper
• Serum cholesterol and the risk of developing hormonally driven cancers: A narrative review

  2022cites this paper
• Journal Pre-proof Interplay between fatty acids, SCD, mTORC1 and YAP/TAZ in promoting hepatocellular carcinoma

  2022cites this paper
• Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor

  2022cites this paper
• Deregulation of Cholesterol Homeostasis by a Nuclear Hormone Receptor Crosstalk in Advanced Prostate Cancer

  2022cites this paper
• Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression

  2022cites this paper
• The association between serum lipid levels and histological type of breast cancer

  2022cites this paper
• A Sterol-PI(4)P exchanger controls the Tel1/ATM axis of the DNA Damage Response

  2022cites this paper
• Interplay Between Fatty Acids, Stearoyl-Co-A Desaturase, Mechanistic Target of Rapamycin, and Yes-Associated Protein/Transcriptional Coactivator With PDZ-Binding Motif in Promoting Hepatocellular Carcinoma

  2022cites this paper
• Lipidomic and Membrane Mechanical Signatures in Triple-Negative Breast Cancer: Scope for Membrane-Based Theranostics

  2022cites this paper
• Insight into the Evolving Role of PCSK9

  2022cites this paper
• Identification of hypoxia-related prognostic signature for ovarian cancer based on Cox regression model

  2022cites this paper
• Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study

  2022influential citation
• Exploring BODIPY-Based Sensor for Imaging of Intracellular Microviscosity in Human Breast Cancer Cells

  2022cites this paper
• Long non-coding RNAs affecting cell metabolism in cancer

  2022cites this paper
• Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells

  2022cites this paper
• Correlation of cholesteryl ester metabolism to pathogenesis, progression and disparities in colorectal Cancer

  2022cites this paper
• Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential

  2022cites this paper
• Atorvastatin improves cisplatin sensitivity through modulation of cholesteryl ester homeostasis in breast cancer cells

  2022cites this paper
• Lipid metabolism of cancer stem cells

  2022cites this paper
• Impact of HCV Infection on Hepatocyte Polarity and Plasticity

  2022cites this paper
• Defect in Ser312 phosphorylation of Tp53 dysregulates lipid metabolism for fatty accumulation and fatty liver susceptibility: Revealed by lipidomics.

  2022cites this paper
• Mechanistic Insights Delineating the Role of Cholesterol in Epithelial Mesenchymal Transition and Drug Resistance in Cancer

  2021cites this paper
• Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients

  2021cites this paper
• S1P signaling, its interactions and cross-talks with other partners and therapeutic importance in colorectal cancer.

  2021cites this paper
• LDLR promotes growth and invasion in renal cell carcinoma and activates the EGFR pathway.

  2021cites this paper
• LRP-1 Matricellular Receptor Involvement in Triple Negative Breast Cancer Tumor Angiogenesis

  2021cites this paper
• Lipid metabolism reprogramming in renal cell carcinoma

  2021cites this paper
• Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy

  2021cites this paper
• Connecting Cholesterol Efflux Factors to Lung Cancer Biology and Therapeutics

  2021cites this paper
• Lipidomic and metabolomic analysis reveals changes in biochemical pathways for non-small cell lung cancer tissues.

  2021cites this paper
• Sirtuins and cellular metabolism in cancers

  2021cites this paper
• A Narrative Review of the Role of Diet and Lifestyle Factors in the Development and Prevention of Endometrial Cancer

  2021cites this paper
• Identification of a Positive Association between Mammary Adipose Cholesterol Content and Indicators of Breast Cancer Aggressiveness in a French Population.

  2021cites this paper
• In-silico HMG-CoA reductase-inhibitory and in-vivo anti-lipidaemic/anticancer effects of carotenoids from Spondias mombin.

  2021cites this paper
• Influence of cholesterol on cancer progression and therapy

  2021cites this paper
• Lipid Metabolism in Cancer Cells.

  2021cites this paper
• Overview: Lipid Metabolism in the Tumor Microenvironment.

  2021cites this paper
• Signaling, metabolism, and cancer: An important relationship for therapeutic intervention

  2021cites this paper